Vycor Medical (VYCO) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,240.00 |
| Dec 31, 2025 | -48,657.00 |
| Sep 30, 2025 | 8,099.00 |
| Jun 30, 2025 | 9,489.00 |
| Mar 31, 2025 | 4,120.00 |
| Dec 31, 2024 | 35,021.00 |
| Sep 30, 2024 | -7,200.00 |
| Jun 30, 2024 | -3,839.00 |
| Mar 31, 2024 | -6,047.00 |
| Dec 31, 2023 | 12,226.00 |
| Sep 30, 2023 | -5,004.00 |
| Jun 30, 2023 | -12,409.00 |
| Mar 31, 2023 | -9,838.00 |
| Dec 31, 2022 | 23,106.00 |
| Sep 30, 2022 | 7,678.00 |
| Jun 30, 2022 | 8,743.00 |
| Mar 31, 2022 | 4,950.00 |
| Dec 31, 2021 | 7,260.00 |
| Sep 30, 2021 | 10,419.00 |
| Jun 30, 2021 | 8,068.00 |
| Mar 31, 2021 | 5,384.00 |
| Dec 31, 2020 | 63,004.00 |
| Sep 30, 2020 | 12,866.00 |
| Jun 30, 2020 | 5,723.00 |
| Mar 31, 2020 | 17,039.00 |
| Sep 30, 2019 | 45,903.00 |
| Jun 30, 2019 | 46,415.00 |
| Mar 31, 2019 | 27,146.00 |
| Dec 31, 2018 | 6,739.00 |
| Sep 30, 2018 | 19,450.00 |
| Jun 30, 2018 | 41,218.00 |
| Mar 31, 2018 | 38,651.00 |
| Dec 31, 2017 | 5,417.00 |
| Sep 30, 2017 | 24,368.00 |
| Jun 30, 2017 | 18,336.00 |
| Mar 31, 2017 | 10,808.00 |
| Dec 31, 2016 | 5,263.00 |
| Sep 30, 2016 | 39,497.00 |
| Jun 30, 2016 | 120,895.00 |
| Mar 31, 2016 | 51,290.00 |
| Dec 31, 2015 | 66,708.00 |
| Sep 30, 2015 | 29,269.00 |
| Jun 30, 2015 | 41,468.00 |